Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    North America Self-Monitoring Blood Glucose (SMBG) Devices Market Forecast 2027 By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: January 2022   |   Report ID: GR1021   |   Delivery: PDF  Request Free Sample

    North America Self-Monitoring Blood Glucose Devices Market size exceeded USD 7,133.6 million in 2020 and is anticipated to expand at a CAGR of 9.6% from 2021 to 2027. Increasing healthcare expenditure associated with diabetes in the region will contribute to market expansion.

    North America Self-Monitoring Blood Glucose Devices Market

    Get more details on this report - Request Free Sample PDF

    Growing prevalence of diabetes in North America will boost the usage of self-monitoring blood glucose devices due to need of routine blood glucose monitoring. According to the data published by the Centers for Disease Control and Prevention, in 2020, one among three people had prediabetes and 34.2 million Americans had diabetes. In addition, increasing consumption of carbohydrate-rich food coupled with prevalence of obesity will further contribute to disease burden, thereby stimulating the demand for SMBG devices. Also, geriatric population is prone to diabetes that further increases the market demand.

    COVID-19 pandemic has positively impacted the SMBG devices market. Diabetic people are more likely to suffer from the COVID-19. In addition, the pandemic has prompted a boom in the use of self-monitoring blood glucose monitors in home settings, reducing the number of visits to healthcare settings.

    North America Market, By Product

    Continuous glucose monitors segment held more than 10% market share in 2020. Continuous glucose monitors are one of the recent technological advancements in diabetes management. Rising awareness regarding diabetes preventive care has led to high adoption of continuous glucose monitors in recent years. Adding to this, increasing demand for user-friendly homecare devices along with FDA approvals for new CGMs in the region will impel the segment growth.

    North America Market, By Application

    The type 2 diabetes segment dominated over 90% North America market share in 2020. Increasing adoption of unhealthy habits such as unhealthy diet and tobacco consumption along with obesity are accountable factors for the onset of type 2 diabetes mellitus (T2DM). Additionally, growing population aged over 45 years that is susceptible to type 2 diabetes is adding to the total patient population. According to CDC, 34 million Americans have diabetes and around 90-95% of them have type 2 diabetes. With growing customer pool coupled with requirement for timely monitoring will augment the market demand for various SMBG devices among T2DM population in the region.

    North America Market, By Distribution Channel

    Retail pharmacies segment accounted around USD 1.9 billion revenue in 2020. Diabetes patients require timely monitoring of blood glucose levels. Self-monitoring blood glucose devices are easily available at retail pharmacies at variable rate with availability of several discounts and offers. Adding to this, improvement in medical infrastructure, expanding pharmacies and increase in disposable income will positively impact distribution of SMBG devices through retail pharmacies in future.

    North America Market, By Country

    The U.S. self-monitoring blood glucose devices market was valued at over USD 6 billion in 2020. The domestic market growth is attributed to increasing prevalence of chronic diseases due to change in lifestyle and eating habits, leading to high demand for diabetes products. Additionally, numerous companies operating and based in the U.S. are launching novel devices in the country. Further, availability of reimbursement for SMBG devices including CGM will influence the market expansion.

    Competitive Industry Landscape

    Eminent players engaged in the market include Abbott Laboratories, Arkray, Bayer Healthcare, Dexcom, F. Hoffmann-La Roche and Johnson & Johnson, among others.

    These companies are undertaking various strategies to develop innovative and advanced products in order to acquire significant market share. For instance, in August 2021, Abbott received U.S. FDA clearance for the use of FreeStyle Libre 2 iOS application with compatible iPhones, thereby providing a comprehensive digital offering. The FreeStyle Libre portfolio is widely used continuous glucose monitoring (CGM) system and mostly prescribed in the U.S.

    Frequently Asked Question(FAQ) :

    How big is North America self-monitoring blood glucose (SMBG) devices market?
    The market value for self-monitoring blood glucose (SMBG) devices in North America was surpassed $7.1 billion in 2020 and is anticipated to register 9.6% CAGR during the forecast period of 2021-2027.
    How will North America SMBG devices industry share gain traction from continuous glucose monitors?
    Continuous glucose monitors held over 10% share of the industry in 2020 as the awareness of preventive care for diabetes and demand for user-friendly homecare devices is steadily growing among the regional population.
    What may be the most effective application of SMBG devices?
    Type 2 diabetes captured more than 90% share of the market in 2020 as the devices can help patients diagnosed with the ailment keep an accurate and timely track of their blood glucose levels.
    Why are retail pharmacies gaining popularity in North America SMBG devices sector?
    The overall market revenue from retail pharmacies reached $1.9 billion in 2020 as SMBG devices are readily available at these distribution channels at affordable rates.
    Which are the companies leading North America SMBG devices landscape?
    Renowned organizations, including Abbott Laboratories, Bayer Healthcare, Arkray, Johnson & Johnson, Dexcom, and F. Hoffmann-La Roche, among others, are positively affecting the market trends.

    Get this research report on North America Self-Monitoring Blood Glucose Devices Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]